周宇飞;罗钢;任维;毛琳慎;杨思进;

• 1:西南医科大学附属中医医院国家中医药临床研究基地

摘要(Abstract)：

中药治疗冠心病具有多靶点、多成分协同作用的特点，在临床防治冠心病心绞痛中独具优势，但其复杂的成分为研究带来了难度。代谢组学是一门研究生物体内代谢物及代谢途径的新兴学科，能够整体、动态地反映生物体内代谢表征及变化，与中医学的整体观相吻合，为中药治疗冠心病的研究提供了新方法。本文综述了近年来基于代谢组学冠心病心绞痛中医证候生物学基础及中药治疗冠心病心绞痛的研究进展。

关键词(KeyWords)： 冠心病;中医药;代谢组学;中医证型;综述

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金项目（82074378）;; 四川省中医药管理局中医药科研专项（2021ZD05）;; 四川大学-泸州市人民政府战略合同项目（2018CDLZ-12）

作者(Authors): 周宇飞;罗钢;任维;毛琳慎;杨思进;

参考文献(References)：

• [1]胡盛寿，高润霖，刘力生，等.《中国心血管病报告2018》概要[J].中国循环杂志，2019,3(34):209-220.
• [2] Ullah E,El-Menyar A,K Kunji,et al. Metabolomics reveals perturbations in arginine-no metabolism,purine biosynthesis and cellular energy charge in patients with coronary heart disease[J]. Journal of the American College of Cardiology,77(18):106-112.
• [3] Ali SE,Farag MA,Holvoet P,et al. A comparative metabolomics approach reveals early biomarkers for metabolic response to acute myocardial infarction[J]. Scientific Reports,2016,6(1):36359.
• [4] Ignasi B,Mireia A,David GD. Metabolomics and heart diseases:from basic to clinical approach[J]. Current Medicinal Chemistry,2019,26(1):46-59.
• [5] Fu H,Zhu K,Zhou D,et al. Identification and validation of plasma metabolomics reveal potential biomarkers for coronary heart disease[J]. International Heart Journal,2019,60(6):1387-1397.
• [6] Zhu M,Han Y,Zhang Y,et al. Metabolomics study of the biochemical changes in the plasma of myocardial infarction patients[J]. Frontiers in Physiology,2018,9:1017.
• [7]王继红，郝小龙，郑梅，等.冠状动脉造影对非心脏手术围术期心血管风险评估的价值[J].中国医药，2021,16(12):1787-1790.
• [8] Tomas L,Edsfeldt A,Mollet IG,et al. Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques[J]. European Heart Journal,2018,39(24):2301-2310.
• [9] Wang X,Wang D,Wu J,et al. Metabolic characterization of myocardial infarction using GC-MS-Based tissue metabolomics[J]. International Heart Journal,2017,58(3):441-446.
• [10] Zhang L,Wei TT,Li Y,et al. Functional metabolomics characterizes a key role for N-acetylneuraminic acid in coronary artery diseases[J]. Circulation,2018,137(13):1374.
• [11] Würtz P,Havulinna AS,Soininen P,et al. Metabolite profiling and cardiovascular event risk[J]. Circulation,2015,131(9):774-785.
• [12] Lu XY,Xu H,Zhao T,et al. Study of serum metabonomics and formula-pattern correspondence in coronary heart disease patients diagnosed as phlegm or blood stasis pattern based on ultra performance liquid chromatography mass spectrometry[J]. Chin J Integr Med,2018,24(12):905-911.
• [13] Zhao L,Wan L,Qiu X,et al. A metabonomics profiling study on phlegm syndrome and blood-stasis syndrome in coronary heart disease patients using liquid chromatography/quadrupole time-of-flight mass spectrometry[J]. Evid Based Complement Alternat Med,2014,2014:385102.
• [14] Zhao LL,Qiu XJ,Wang WB,et al. NMR metabolomics and random forests models to identify potential plasma biomarkers of blood stasis syndrome with coronary heart disease patients[J]. Frontiers in Physiology,2019,10:1109.
• [15]李静，钟森杰，李亮，等.基于尿液代谢组学的冠心病血瘀证模型大鼠生物学基础研究[J].中国中医药信息杂志，2021,28(3):63-68.
• [16]具星，贾连群，吕美君，等.冠心病心绞痛痰瘀互结证与非痰瘀互结证患者血清代谢组学差异[J].中华中医药杂志，2020,35(2):599-603.
• [17]朱黎霞，韦园诗，黄星星，等.基于UPLC-Q/TOF-MS的痰瘀互结型冠心病患者尿液脂质组学研究[J].辽宁中医杂志，2020,47(7):26-32.
• [18]朱黎霞，韦园诗，黄星星，等.基于UPLC-Q/TOF-MS分析痰瘀互结型冠心病患者的血浆脂质组学[J].中国实验方剂学杂志，2020,26(1):110-117.
• [19]杨小芳，王茹，何鹏彬，等.冠心病心绞痛气滞血瘀证和气虚血瘀证血清中氨基酸代谢组学研究[J].世界中医药，2020,15(10):1484-1488.
• [20] Zhou H,Li L,Zhao H,et al. A large-scale,multi-center urine biomarkers identification of coronary heart disease in TCM syndrome differentiation[J]. J Proteome Res,2019,18(5):1994-2003.
• [21]魏岩，郭家娟，崔英子，等.基于核磁共振的冠心病心绞痛先天伏寒证的代谢组学研究[J].中华中医药杂志，2013,28(12):3556-3558.
• [22]赵文兰.胸痹心痛汤治疗冠心病心绞痛气滞血瘀证临床疗效[J].内蒙古中医药，2022,41(3):68-69.
• [23]肖涛，张安武，程小娟，等.瓜蒌薤白半夏汤联合阿司匹林对冠心病心绞痛急性发作患者疗效及凝血功能的影响[J].中国中医急症，2022,31(3):483-485.
• [24]陈淑华，章琪.血栓心脉宁联合阿托伐他汀对老年冠心病不稳定型心绞痛患者的疗效及对血浆MMP-9、ET-1、氧化应激和炎性因子水平的影响[J].中国老年学杂志，2022,42(4):788-791.
• [25]汪傲楠，隋月皎.血府逐瘀汤（煎剂）治疗冠心病心绞痛的临床疗效观察[J].按摩与康复医学，2021,12(24):44-46.
• [26]王晓杰，杨科.人参养荣汤合桃红四物汤治疗冠心病心绞痛（瘀阻脉络型）的疗效及对血清Asprosin、NT-proBNP和Hcy的影响[J].四川中医，2021,39(11):72-74.
• [27]魏燕，赵洋，张炜.精制冠心片治疗冠心病心绞痛的临床疗效观察[J].海峡药学，2020,32(7):132-133.
• [28]庞建中，杨继，陈善夫，等.通脉养心丸治疗气阴两虚型稳定型心绞痛疗效观察[J].现代中西医结合杂志，2021,30(23):2513-2517,2544.
• [29] Tao T,He T,Mao H,et al. Non-targeted metabolomic profiling of coronary heart disease patients with taohong Siwu Decoction treatment[J]. Frontiers in Pharmacology,2020,11.
• [30] Tao T,He T,Wang X,et al. Metabolic profiling analysis of patients with coronary heart disease undergoing Xuefu Zhuyu Decoction treatment[J]. Frontiers in Pharmacology,2019,10(985).
• [31] Zhao L,Qiu X,Wang R,et al. 1H NMR-based metabolomics study of the dynamic effect of Xue-Fu-Zhu-Yu capsules on coronary heart disease rats induced by high-fat diet,coronary artery ligation[J]. Journal of Pharmaceutical and Biomedical Analysis,2021,195:113869.
• [32] Aa N,Guo JH,Cao B,et al. Compound danshen dripping pills normalize a reprogrammed metabolism of myocardial ischemia rats to interpret its time-dependent efficacy in clinic trials:a metabolomic study[J]. Metabolomics,2019,15(10):128.
• [33] Guo J,Yong Y,Aa J,et al. Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia[J]. Scientific Reports,2016,6(1):37919.
• [34] Tan J,Wang C,Zhu H,et al. Comprehensive metabolomics analysis of Xueshuan Xinmaining Tablet in blood stasis model rats using UPLC-Q/TOF-MS[J]. Molecules,2018,23(7):16.
• [35] Li Z,Yang L,Liu Y,et al. Anti-inflammatory and antioxidative effects of Dan-Lou tablets in the treatment of coronary heart disease revealed by metabolomics integrated with molecular mechanism studies[J]. J Ethnopharmacol,2019,240:111911.
• [36] Cai X,Du J,Li L,et al. Clinical metabolomics analysis of therapeutic mechanism of Tongmai Yangxin Pill on stable angina[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2018,1100:106-112.
• [37] Jiang M,Wang Q,Chen J,et al. Comparative metabonomics of Wenxin Keli and Verapamil reveals differential roles of gluconeogenesis and fatty acid beta-oxidation in myocardial injury protection[J]. Scientific Reports,2017,7(1):106-112.
• [38]魏岩，姜丽红，郭家娟，等.伏寒颗粒对冠心病先天伏寒证患者治疗后的血清代谢组学研究[J].世界科学技术-中医药现代化，2018,20(5):744-749.